IDEXX Laboratories (IDXX)
(Delayed Data from NSDQ)
$494.26 USD
+0.46 (0.09%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $495.29 +1.03 (0.21%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth C Momentum C VGM
Price, Consensus and EPS Surprise
IDXX 494.26 +0.46(0.09%)
Will IDXX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for IDXX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for IDXX
Penumbra's (PEN) New Launch to Enhance Blood Clot Removal
Reasons Why You Should Retain HealthEquity (HQY) Stock for Now
IDXX: What are Zacks experts saying now?
Zacks Private Portfolio Services
GE HealthCare's (GEHC) New Tie-Up to Boost Patient Outcomes
What Lies Ahead of IDEXX Laboratories (IDXX) in Q1 Earnings?
TMO vs. IDXX: Which Stock Is the Better Value Option?
Other News for IDXX
Baron Focused Growth Fund Q1 2024 Shareholder Letter
Eaton Vance Worldwide Health Sciences Fund Bolsters Position in IDEXX Laboratories
Top 10 most oversold S&P 500 stocks
Commit To Buy Idexx Laboratories At $320, Earn 1.4% Annualized Using Options
$1000 Invested In IDEXX Laboratories 10 Years Ago Would Be Worth This Much Today